The Cancer Center at the University of Texas Health Science Center at San Antonio requests $35,200 in support of the Planning and Evaluation process. The Cancer Center has both an External Advisory Board (EAB) and three Internal Advisory Committees, the Executive Committee (EC) for the day to day management, the Scientific Leadership Committee (SLC) for scientific programs and shared resources development and review and the Internal Advisory Committee for more global issues related to the various Schools and the UTHSCSA in general. The Cancer Center Director and leadership interact very closely with it's EAB through many telephone conferences, sending documents for review on a regular basis by on-site visits by the Chair, Dr. John C. Ruckdeschel, members of the EAB and by an annual visit of the EAB. the EAB reviews and advices Director on all activities of the Cancer Center. Their reviews, evaluations and criticisms have led us to develop much stronger Cancer Center Funds to support the EAB are requested ($25,000). The EC and the SLC work very closely together and with the EAB for Strategic planning and evaluations of the programs and shared resources. The Cancer Center uses center-wide retreats and program retreats to further develop strong and effective programs and shared resources and for future recruitment strategies. We request $10,000 to help with the Cancer Center and program retreats.

Public Health Relevance

The CTRC is in a historic period of transition and re-growth after a period of turnnoil and attrition of key personnel. Planning and evaluation funds are critical to maintain our ability to bring in our EAB, and to compensate them for the visits and for grant reviews. Funds for retreats and other meetings of programs are also to maintain the momentum generated by the merger and by the new leadership. These funds help rebuild and further strengthen programs through appropriate planning and evaluation during a transition period.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA054174-19
Application #
8320954
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
2014-07-31
Budget Start
2011-08-01
Budget End
2013-07-31
Support Year
19
Fiscal Year
2011
Total Cost
$21,908
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Chalela, Patricia; Muñoz, Edgar; Gallion, Kipling J et al. (2018) Empowering Latina breast cancer patients to make informed decisions about clinical trials: a pilot study. Transl Behav Med 8:439-449
Chalela, P; Munoz, E; Inupakutika, D et al. (2018) Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial. Contemp Clin Trials Commun 12:109-115
Liu, Jinyou; Sareddy, Gangadhara R; Zhou, Mei et al. (2018) Differential Effects of Estrogen Receptor ? Isoforms on Glioblastoma Progression. Cancer Res 78:3176-3189
Weiner, Marc; Gelfond, Jon; Johnson-Pais, Teresa L et al. (2018) Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis. Antimicrob Agents Chemother 62:
Chakravarthy, Divya; Muñoz, Amanda R; Su, Angel et al. (2018) Palmatine suppresses glutamine-mediated interaction between pancreatic cancer and stellate cells through simultaneous inhibition of survivin and COL1A1. Cancer Lett 419:103-115
Van Skike, Candice E; Jahrling, Jordan B; Olson, Angela B et al. (2018) Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol 314:H693-H703
Cooney, Jeffrey D; Lin, An-Ping; Jiang, Daifeng et al. (2018) Synergistic Targeting of the Regulatory and Catalytic Subunits of PI3K? in Mature B-cell Malignancies. Clin Cancer Res 24:1103-1113
Zhu, Haiyan; Gu, Xiang; Xia, Lu et al. (2018) A Novel TGF? Trap Blocks Chemotherapeutics-Induced TGF?1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers. Clin Cancer Res 24:2780-2793
Bandyopadhyay, Abhik; Favours, Edward; Phelps, Doris A et al. (2018) Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models. Pediatr Blood Cancer 65:
Azpurua, Jorge; Mahoney, Rebekah E; Eaton, Benjamin A (2018) Transcriptomics of aged Drosophila motor neurons reveals a matrix metalloproteinase that impairs motor function. Aging Cell 17:

Showing the most recent 10 out of 989 publications